Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
Waun Ki Hong(The University of Texas MD Anderson Cancer Center), Helmuth Goepfert(The University of Texas MD Anderson Cancer Center), Alan Kramer(The University of Texas MD Anderson Cancer Center), Loretta M. Itri(National Institutes of Health), Jin S. Lee(The University of Texas MD Anderson Cancer Center), Stimson P. Schantz(The University of Texas MD Anderson Cancer Center), Robert M. Byers(The University of Texas MD Anderson Cancer Center), S. M. Lippman(The University of Texas MD Anderson Cancer Center), Lester J. Peters(Peter MacCallum Cancer Centre), Isaiah W. Dimery(The University of Texas MD Anderson Cancer Center), R. Lotan(The University of Texas MD Anderson Cancer Center), Daniel D. Karp(The University of Texas MD Anderson Cancer Center)
Cited by 1,385
Related Papers
Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
|The Oncologist|2000|1.3k
Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
|International Journal of Radiation Oncology*Biology*Physics|1982|842
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.
|PubMed|1997|771
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741